BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33028635)

  • 1. Dysregulation of hsa-miR-34a and hsa-miR-449a leads to overexpression of PACS-1 and loss of DNA damage response (DDR) in cervical cancer.
    Veena MS; Raychaudhuri S; Basak SK; Venkatesan N; Kumar P; Biswas R; Chakrabarti R; Lu J; Su T; Gallagher-Jones M; Morselli M; Fu H; Pellegrini M; Goldstein T; Aladjem MI; Rettig MB; Wilczynski SP; Shin DS; Srivatsan ES
    J Biol Chem; 2020 Dec; 295(50):17169-17186. PubMed ID: 33028635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamical modeling of miR-34a, miR-449a, and miR-16 reveals numerous DDR signaling pathways regulating senescence, autophagy, and apoptosis in HeLa cells.
    Gupta S; Panda PK; Hashimoto RF; Samal SK; Mishra S; Verma SK; Mishra YK; Ahuja R
    Sci Rep; 2022 Mar; 12(1):4911. PubMed ID: 35318393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR-34a pathway.
    Wang X; Meyers C; Guo M; Zheng ZM
    Int J Cancer; 2011 Sep; 129(6):1362-72. PubMed ID: 21128241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and significance of microRNAs in the p53 pathway in ovarian cancer cells and serous ovarian cancer tissues].
    Zhang Q; He XJ; Ma LP; Li N; Yang J; Cheng YX; Cui H
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):885-90. PubMed ID: 22340095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.
    Li B; Guo X; Li N; Chen Q; Shen J; Huang X; Huang G; Wang F
    Cell Oncol (Dordr); 2020 Jun; 43(3):489-503. PubMed ID: 32301035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-375 Modulates Radiosensitivity of HR-HPV-Positive Cervical Cancer Cells by Targeting UBE3A through the p53 Pathway.
    Song L; Liu S; Zeng S; Zhang L; Li X
    Med Sci Monit; 2015 Jul; 21():2210-7. PubMed ID: 26224081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of lncRNA-NEAT1 sensitizes 5-Fu resistant cervical cancer cells through de-repressing the microRNA-34a/LDHA axis.
    Shao X; Zheng X; Ma D; Liu Y; Liu G
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 33645623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells.
    Zheng SZ; Sun P; Wang JP; Liu Y; Gong W; Liu J
    World J Gastroenterol; 2019 Jun; 25(22):2752-2762. PubMed ID: 31235998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection.
    Li B; Hu Y; Ye F; Li Y; Lv W; Xie X
    Int J Gynecol Cancer; 2010 May; 20(4):597-604. PubMed ID: 20442590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micro(mi) RNA-34a targets protein phosphatase (PP)1γ to regulate DNA damage tolerance.
    Takeda Y; Venkitaraman AR
    Cell Cycle; 2015; 14(24):3830-41. PubMed ID: 26111201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-34a modulates MDM4 expression via a target site in the open reading frame.
    Mandke P; Wyatt N; Fraser J; Bates B; Berberich SJ; Markey MP
    PLoS One; 2012; 7(8):e42034. PubMed ID: 22870278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsa_circ_0031288/hsa-miR-139-3p/Bcl-6 regulatory feedback circuit influences the invasion and migration of cervical cancer HeLa cells.
    Xu YJ; Yu H; Liu GX
    J Cell Biochem; 2020 Oct; 121(10):4251-4260. PubMed ID: 32277518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
    Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
    PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsa_circ_0023404 enhances cervical cancer metastasis and chemoresistance through VEGFA and autophagy signaling by sponging miR-5047.
    Guo J; Chen M; Ai G; Mao W; Li H; Zhou J
    Biomed Pharmacother; 2019 Jul; 115():108957. PubMed ID: 31082770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-148b Acts as a Tumor Suppressor in Cervical Cancer by Inducing G1/S-Phase Cell Cycle Arrest and Apoptosis in a Caspase-3-Dependent Manner.
    Mou Z; Xu X; Dong M; Xu J
    Med Sci Monit; 2016 Aug; 22():2809-15. PubMed ID: 27505047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Micro-RNA-492 (MiR-492) in Human Cervical Cancer Cell Lines is Upregulated by Transfection with Wild-Type P53, Irradiation, and 5-Fluorouracil Treatment In Vitro.
    Liu M; Wang Z; Liu Q; Zhu H; Xu N
    Med Sci Monit; 2018 Oct; 24():7750-7758. PubMed ID: 30374014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.
    Chang TC; Wentzel EA; Kent OA; Ramachandran K; Mullendore M; Lee KH; Feldmann G; Yamakuchi M; Ferlito M; Lowenstein CJ; Arking DE; Beer MA; Maitra A; Mendell JT
    Mol Cell; 2007 Jun; 26(5):745-52. PubMed ID: 17540599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
    Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S
    Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RNA-binding protein SART3 promotes miR-34a biogenesis and G
    Sherman EJ; Mitchell DC; Garner AL
    J Biol Chem; 2019 Nov; 294(46):17188-17196. PubMed ID: 31619517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
    Luan S; Sun L; Huang F
    Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.